Cardium Therapeutics Chooses OmniComm Systems Inc. Over Competing EDC Vendors As Its Web-Based Data Collection And Management Solution

FT. LAUDERDALE, FL – April 2, 2007 – /MarketWire/ - OmniComm Systems, Inc. (OTC Bulletin Board: OMCM.OB), one of the fastest growing companies in the EDC marketplace, today announced that Cardium Therapeutics of San Diego, CA has selected the TrialMaster EDC solution for conducting a Phase 3 study in women which will evaluate Generx™ (alferminogene tadenovec) as a potential treatment for myocardial ischemia (insufficient blood flow within the heart muscle).

Read More

OmniComm Raises Financing of $3.4 Million and Announces Conversion of Debt

FT. LAUDERDALE, FL – March 12, 2007 – /MarketWire/ - OmniComm Systems, Inc. (OTC Bulletin Board: OMCM.OB), one of the fastest growing companies in the EDC marketplace, announced that it has completed a $3.4 million equity private placement. Noesis Capital Corp. of Boca Raton, Florida acted as placement agent.

Read More

OmniComm Systems, Inc. Sr. VP of Sales & Marketing Featured in Exclusive Interview With WallSt.net

NEW YORK, Feb. 20 /PRNewswire/ -- On February, 15, Stephen Johnson, Senior Vice President of Sales and Marketing for OmniComm Systems, Inc. (OTC Bulletin Board: OMCM - News) updated the investment community in an exclusive interview with www.wallst.net.

Read More

Proven Informatics Solutions Provider for the National Institutes of Health (NIH) Partners with Premier EDC Company to deliver 1st Kind eClinical Solution for Drug Development

CTIS, Inc. and OmniComm Systems, Inc. sign a strategic alliance deal to offer clinical trial sponsors a complete trial research and management informatics integration initiative.

Read More

OmniComm Systems Appoints Simon Kooyman to Board of Directors Announces Director Resignation

FT. LAUDERDALE, FL – January 9, 2007 – /MarketWire/ - OmniComm Systems, Inc. (OTC Bulletin Board: OMCM), one of the fastest growing companies in the EDC marketplace, today announced that it will partner with Capital Technology Information Services, Inc.

Read More

OmniComm Systems, Inc. Announces Second Quarter 2006 Results

2006 Signed contracts increase to $4.3 million – an increase of 160% over 2005 results. Contract backlog increases to $1.6 million.

Ft. Lauderdale, Florida – July 11, 2006 - /MarketWire/ - OmniComm Systems, Inc. (OTC Bulletin Board: OMCM), one of the fastest growing companies in the EDC marketplace, today announced that it had achieved record contracts for the first half of a fiscal year. The Company reported that it had signed new contracts totaling approximately $4.3 million during the first half of 2006 compared with new contracts signed in the first half of 2005 of approximately $1.65 million, an increase of approximately 160%. The Company signed contracts for 21 new clinical trials.

Read More

OmniComm Systems Inc., Introduces New TrialMaster V.4.0 At the Dia's 42nd Annual Meeting in Philadelphia

June 18-20th 2006 / Booth #1144

Ft. Lauderdale, Florida – June 18th, 2006 - - /MarketWire/ - OmniComm Systems, Inc. (OTC Bulletin Board: OMCM), one of the fastest growing companies in the EDC marketplace, announced today the launch of TrialMaster™ Version 4.0 eClinical trial solution. 

Read More

OmniComm Participating in Life Science Workshop Series – A Collaborative Approach to Clinical Trials Management

May 23rd and May 25th, 2006

OmniComm will be speaking at two complimentary seminars, hosted by IBM, designed to help life sciences professionals address the complex issues involved in clinical trial management today. Industry experts from OmniComm, Winchester Business Systems and Averion will talk about the benefits and areas of potential savings from the use of collaborative electronic trial management systems through a centralized and shared approach.

Read More

Spectrum Pharmaceutical Research Corporation Standardizes on OmniComm’s TrialMaster EDC Solution

Ft. Lauderdale, Florida – April 20, 2006 - /MarketWire/ - OmniComm Systems, Inc. (OTC Bulletin Board: OMCM), one of the fastest growing companies in the EDC marketplace, announced today that it has entered into a strategic partnership with Spectrum Pharmaceutical Research Corporation, a Contract Research Organization (CRO) located in San Antonio, TX.

Read More

OmniComm Systems, Inc. Expands Its Business Development and Clinical Services and Support Team in US and Europe

Ft. Lauderdale, Florida – April 10, 2006 - /MarketWire/ - OmniComm Systems, Inc. (OTC Bulletin Board: OMCM), one of the fastest growing companies in the EDC marketplace, announced today that due to accelerating sales and adoption of the TrialMaster eClinical suite of products and services, the following promotions and additions have been implemented.

Read More

OmniComm Systems, Inc. Announces First Quarter 2006 Results
Signed Contracts Increase to $2.2 Million During Quarter – a 213% Increase.

Ft. Lauderdale, Florida – April 5, 2006 - /MarketWire/ - OmniComm Systems, Inc. (OTC Bulletin Board: OMCM), one of the fastest growing companies in the EDC marketplace, today announced record quarterly contracts. The Company reported that it had signed new contracts totaling approximately $2.2 million during the first quarter of 2006 compared with new contracts signed in the first quarter of 2005 of $702 thousand, an increase of approximately 213%. The Company signed contracts for 13 new clinical trials during the quarter including relationships with five new clients.

Read More

OmniComm's TrialMaster to be Used by Columbia University's InCHOIR as Part of $17 Million NIH Sponsored SCCOR Studies

Ft. Lauderdale, Florida – March 22, 2006 - /MarketWire/ - OmniComm Systems, Inc. (OTC Bulletin Board: OMCM), one of the fastest growing companies in the EDC marketplace, announced today that the company's TrialMaster EDC product has been selected by Columbia University's International Center for Health Outcomes and Innovative Research (InCHOIR) as part of a $17 Million dollar National Institutes of Health (NIH) sponsored Specialized Centers of Clinically Oriented Research (SCCOR) grant entitled Biology of Human Long-term Mechanical Circulatory Support. TrialMaster will be used in six SCCOR studies involving infection and coagulation surveillance, and cell therapy.

Read More

OmniComm Systems, Inc. Announces Strong Growth For 2005 Company Sets New Annual Revenue Record With 60% Growth; Signed Contracts Increase to $4.1 Million in 2005 – a 178% Increase

Ft. Lauderdale, Florida – January 9, 2006 - /MarketWire/ - OmniComm Systems, Inc. (OTC Bulletin Board: OMCM - News), one of the fastest growing companies in the EDC  (Electronic Data Capture) marketplace, today announced a 60% increase in revenues for fiscal 2005. The Company also reported new contracts of $4.1 million signed during 2005 compared with new contracts signed in 2004 of $1.45 million, an increase of approximately 178%.   

Read More

OmniComm Systems, Inc. Ranked 140TH Fastest Growing Technology Company in North America on the 2005 Deloitte Technology Fast 500

Ft. Lauderdale, Florida – October 31, 2005 - /MarketWire/ - OmniComm Systems, Inc. (OTC Bulletin Board: OMCM - News), one of the fastest growing companies in the EDC marketplace, today announced that it ranked Number 140 on the 2005 Deloitte Technology Fast 500, a ranking of the 500 fastest growing technology companies in North America.  Rankings are based on percentage revenue growth over five years, from 2000–2004. OmniComm grew 1,462 percent during this period.

Read More

Ft. Lauderdale, Florida – October 3, 2005 - /MarketWire/ - OmniComm Systems, Inc. (OTC Bulletin Board: OMCM - News), one of the fastest growing companies in the EDC marketplace, announced today that booked contracts in the third quarter 2005 exceeded those of fiscal 2004.

Read More

OmniComm Launches TrialMaster Safety

Ft. Lauderdale, Florida – August 29, 2005 - /MarketWire/ - OmniComm Systems, Inc. (OTC Bulletin Board: OMCM - News), one of the fastest growing companies in the EDC marketplace, announced today that it has released its TrialMaster Safety module. This new TrialMaster solution was developed for our clients in need of a flexible, scalable and affordable safety system to track, manage and communicate Adverse Events (AEs) and Serious Adverse Events (SAEs) through their clinical trial process and beyond.

Read More

Asthmatx Selects OmniComm’s Flexible TrialMaster EDC Solution

Ft. Lauderdale, Florida – August 18, 2005 - /MarketWire/ - OmniComm Systems, Inc. (OTC Bulletin Board: OMCM - News), one of the fastest growing companies in the EDC marketplace, announced today that Asthmatx, Inc. (Mountain View, CA) has selected its TrialMaster Electronic Data Capture (EDC) and Trial Management Solution for conducting its IDE clinical trial of the Alair System for the treatment of asthma.  Asthmatx, a medical device company, is developing a novel investigational device-based procedure called Bronchial Thermoplasty™ for the treatment of asthma.  Asthmatx conducted a thorough evaluation of leading EDC vendors before selecting OmniComm Systems’ unique EDC solution.

Read More

CINRG Awards OmniComm Additional Clinical Trials

Fort Lauderdale, FL, July 19, 2005 -- /MarketWire/ -- OmniComm Systems, Inc. (OTC Bulletin Board: OMCM - News ), one of the fastest growing companies in the EDC marketplace, is pleased to announce that CINRG, the Cooperative International Neuromuscular Research Group, has once again chosen OmniComm’s TrialMaster EDC solution to support two critical upcoming Phase III studies.  CINRG is the clinical research arm of the Duchenne Muscular Dystrophy Research Center (“DMDRC”), and houses its Coordinating Center at the Children’s National Medical Center.  CINRG has been a client of OmniComm since 2001 and has used TrialMaster in three separate Muscular Dystrophy Association sponsored clinical trials.  OmniComm has developed custom software that allows CINRG to dynamically manage, monitor and archive data collected from muscle strength testing devices.

Read More

OmniComm Systems "INKS" 10 New Electronic Data Capture (EDC) Deals In First Quarter 2007

Company secures 4 studies from new customers and adds another 6 studies from existing clients

FT. LAUDERDALE, FL – April 10, 2007 – /MarketWire/ - OmniComm Systems, Inc. (OTC Bulletin Board: OMCM.OB), one of the fastest growing companies in the EDC marketplace, today announced that they have closed 10 new business deals in Q1, 2007. This new business comes from a variety of companies, including Medical Device, Biotechnology, Contract Research Organizations, Academic Medical Centers and Healthcare.

Read More
 

Cardium Therapeutics Chooses OmniComm Systems Inc. Over Competing EDC Vendors As Its Web-Based Bata Collection And Management Solution

FT. LAUDERDALE, FL – April 2, 2007 – /MarketWire/ - OmniComm Systems, Inc. (OTC Bulletin Board: OMCM.OB), one of the fastest growing companies in the EDC marketplace, today announced that Cardium Therapeutics of San Diego, CA has selected the TrialMaster EDC solution for conducting a Phase 3 study in women which will evaluate Generx™ (alferminogene tadenovec) as a potential treatment for myocardial ischemia (insufficient blood flow within the heart muscle).

Read More